Tumour-Specific Uptake of Anti-Cancer Drugs: The Future is Here

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|13|1|4-21

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.13, Iss.1, 2012-01, pp. : 4-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nano Anti-Cancer Drugs: Pros and Cons and Future Perspectives

By  

Current Cancer Drug Targets, Vol. 11, Iss. 2, 2011-02 ,pp. : 131-134

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Modulation of Cytotoxicity and Cellular Uptake of Anti-cancer Drugs by PDE5 Inhibitors in Lung Cancer Cells

By Li Qing   Shu Yan  

Pharmaceutical Research, Vol. 31, Iss. 1, 2014-01 ,pp. : 86-96

Springer Publishing Company

Access to resources Recommend Favorite

Tissue Transport of Anti-cancer Drugs

By  

Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. : 1987-1993

Bentham Science Publishers

Access to resources Recommend Favorite

PI3K/Akt Signalling Pathway Specific Inhibitors: A Novel Strategy to Sensitize Cancer Cells to Anti-Cancer Drugs

By  

Current Pharmaceutical Design, Vol. 16, Iss. 12, 2010-04 ,pp. : 1410-1416

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple Functions of Generic Drugs: Future Perspectives of Aureolic Acid Group of Anti-Cancer Antibiotics and Non-Steroidal Anti-Inflammatory Drugs

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 4, 2008-01 ,pp. : 331-349

Bentham Science Publishers

Access to resources Recommend Favorite